
Sign up to save your podcasts
Or
The hosts kick off by recapping their run club experience because honestly, are you even in your 20s living in a big city if you haven’t gone to a run club yet?
This week, Maya, Anika, and Priya dive into two main stories: Hims & Hers’ new partnership with Novo Nordisk and their upcoming earnings, plus OpenAI’s GPT update and how it ties into the viral “AI 2027” doomsday paper.
Hims & Hers, the public telehealth company, is making headlines after teaming up with Novo Nordisk to offer branded weight loss drugs at a steep discount. The hosts break down the company’s business model, including how they were previously selling generic versions thanks to a supply shortage loophole that just closed. They also get into what Hims’ focus on price transparency could mean for the future of healthcare access in the U.S.Then, they get into the chaotic GPT update that made the model start glazing everyone, so much so that Sam Altman had to hop on X and say “will fix.” The hosts explain what caused the change, how user feedback and model memory played a role, and why no one caught it before release. They also connect the incident to the “AI 2027” paper, which outlines how AI could go off the rails if its incentives aren’t aligned with human values.The episode wraps with Maya crashing out over what her life means if she can’t be a software engineer. To make her feel better, follow us @getthecheckpod on socials and give us 5 stars :)00:00 Intro04:38 Hims & Hers’ Novo Nordisk partnership24:08 GPT update and the viral “AI 2027” paper
5
1616 ratings
The hosts kick off by recapping their run club experience because honestly, are you even in your 20s living in a big city if you haven’t gone to a run club yet?
This week, Maya, Anika, and Priya dive into two main stories: Hims & Hers’ new partnership with Novo Nordisk and their upcoming earnings, plus OpenAI’s GPT update and how it ties into the viral “AI 2027” doomsday paper.
Hims & Hers, the public telehealth company, is making headlines after teaming up with Novo Nordisk to offer branded weight loss drugs at a steep discount. The hosts break down the company’s business model, including how they were previously selling generic versions thanks to a supply shortage loophole that just closed. They also get into what Hims’ focus on price transparency could mean for the future of healthcare access in the U.S.Then, they get into the chaotic GPT update that made the model start glazing everyone, so much so that Sam Altman had to hop on X and say “will fix.” The hosts explain what caused the change, how user feedback and model memory played a role, and why no one caught it before release. They also connect the incident to the “AI 2027” paper, which outlines how AI could go off the rails if its incentives aren’t aligned with human values.The episode wraps with Maya crashing out over what her life means if she can’t be a software engineer. To make her feel better, follow us @getthecheckpod on socials and give us 5 stars :)00:00 Intro04:38 Hims & Hers’ Novo Nordisk partnership24:08 GPT update and the viral “AI 2027” paper
1,737 Listeners
3,134 Listeners
30,044 Listeners
3,780 Listeners
2,290 Listeners
111,077 Listeners
55,962 Listeners
14,275 Listeners
2,940 Listeners
8,756 Listeners
5,361 Listeners
15,007 Listeners
3,534 Listeners
5,106 Listeners
293 Listeners